Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |